Posts Tagged: Bloomberg BNA Life Sciences Law and Industry Report
When Post-Filing Evidence to Determine Written Description Support Is Admissible: Amgen v. Sanofi
May a court rely on post-priority-date evidence offered to show that a patent lacks written description support even though written description is judged based on the state …
